Department of Orthopaedic Surgery, NYU Hospital for Joint Diseases, New York, NY 10003, USA.
J Arthroplasty. 2012 Aug;27(7):1414.e9-1414.e11. doi: 10.1016/j.arth.2011.10.032. Epub 2011 Dec 16.
Fondaparinux is an accepted form of deep venous thrombosis prophylaxis after hip arthroplasty. Cited advantages of its use include once-daily administration, standard dosage, and superiority as compared with enoxaparin. However, there have been several case reports of serious associated bleeding complications. We describe the case of a 77-year-old woman who developed a massive leg hematoma in the operative extremity nearly 3 weeks after a primary total hip arthroplasty while on fondaparinux. The patient developed a compartment syndrome requiring decompression of the hematoma, fasciotomy, and subsequent additional plastic surgery for split thickness skin grafting.
磺达肝癸钠是髋关节置换术后深静脉血栓预防的一种可接受的形式。其使用的优点包括每日一次给药、标准剂量和与依诺肝素相比的优越性。然而,已经有几例严重相关出血并发症的病例报告。我们描述了一位 77 岁女性的病例,她在初次全髋关节置换术后近 3 周时,在使用磺达肝癸钠时,手术肢体出现了巨大的腿部血肿。患者出现了筋膜室综合征,需要对血肿进行减压、筋膜切开术,随后还需要进行额外的整形手术,进行断层皮片移植。